Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SJP-0170 Phase I Pharmacokinetic Study in Healthy Adults
jRCT2051240176Phase 1Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Simbrinza (2 arms), sponsored by Senju Pharmaceutical Co., Ltd. Primary endpoints: Pharmacokinetics of SJP-0170 and Safety and tolerability. Started Nov 2024; status: completed.
02
Drugs
Simbrinza
Beyond the preview
Go deeper on jRCT2051240176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051240176.